- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04429997
Incidence of Patellar Crepitus in Removal and Non-removal of Fibrosynovial Tissue at Superior Pole of Patella
August 30, 2021 updated by: Satit Thiengwittayaporn, Navamindradhiraj University
Prospective Randomized Controlled Trial: Comparison of Incidence of Patellar Crepitus Between Removal and Non-removal of Fibrosynovial Tissue at the Border of the Superior Pole of the Patellar
The purpose of this study is to compare the incidence of patellar crepitus complication and the clinical outcome between remove and not remove fibrosynovial tissue at the border of the superior pole of the patellar in posterior stabilized total knee arthroplasty.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
138
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bangkok,
-
Dusit, Bangkok,, Thailand, 10300
- Navamindradhiraj University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Primary osteoarthritis of knee who were scheduled for a primary total knee arthroplasty
Exclusion Criteria:
- Valgus deformity
- History of inflammatory arthroplathy
- Previous fracture or open surgery on the same knee
- History of patellar instability
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Removal of fibrosynovial tissue
Removal of fibrosynovial tissue in patellar non-resurfacing TKA
|
Remove of fibrosynovial tissue at the superior border of patella
|
|
Experimental: Non-removal of fibrosynovial tissue
Non-removal of fibrosynovial tissue in patellar non-resurfacing TKA
|
Do not remove of fibrosynovial tissue at the superior border of patella
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of patellar crepitus complication
Time Frame: Change from baseline patellar crepitus complication 3 months, 6 months, and 12 months after surgery
|
Incidence of patellar crepitus complication (present, absent)
|
Change from baseline patellar crepitus complication 3 months, 6 months, and 12 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of post-operative anterior knee pain
Time Frame: Change from baseline Visual Analog Scale for anterior knee pain at 3 months, 6 months, and 12 months after surgery
|
Visual Analog Scale for anterior knee pain (minimum 0, maximum 10) Do higher values represent a worse outcome
|
Change from baseline Visual Analog Scale for anterior knee pain at 3 months, 6 months, and 12 months after surgery
|
|
Knee Society and Knee Society function score
Time Frame: Change from baseline Knee Society and Knee Society function score at 3 months, 6 months, and 12 months after surgery
|
Knee Society and Knee Society function score (minimum 0, maximum 200)
|
Change from baseline Knee Society and Knee Society function score at 3 months, 6 months, and 12 months after surgery
|
|
New patellar score
Time Frame: Change from baseline new patellar score at 3 months, 6 months, and 12 months after surgery
|
New patellar score (minimum 0, maximum 30)
|
Change from baseline new patellar score at 3 months, 6 months, and 12 months after surgery
|
|
Oxford knee score
Time Frame: Change from baseline Oxford knee score 3 months, 6 months, and 12 months after surgery
|
Oxford knee score (minimum 0, maximum 48)
|
Change from baseline Oxford knee score 3 months, 6 months, and 12 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 10, 2020
Primary Completion (Anticipated)
July 1, 2022
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
June 10, 2020
First Submitted That Met QC Criteria
June 10, 2020
First Posted (Actual)
June 12, 2020
Study Record Updates
Last Update Posted (Actual)
August 31, 2021
Last Update Submitted That Met QC Criteria
August 30, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- COA 057/2563
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Removal of Fibrosynovial Tissue
-
RemovAid ASKarolinska Institutet; FHI 360; Mulago Hospital, UgandaCompleted
-
Eye & ENT Hospital of Fudan UniversityCompletedComplication of Device RemovalChina
-
RemovAid ASKarolinska University Hospital; The Research Council of Norway; Bill and Melinda... and other collaboratorsTerminatedRemoval of Contraceptive ImplantSweden
-
RemovAid ASKarolinska University Hospital; The Research Council of Norway; Bill and Melinda... and other collaboratorsTerminated
-
University of California, Los AngelesCompletedRemoval of Toxicity From Dental Bleaching
-
Assaf-Harofeh Medical CenterUnknownRemoval of Colors Tattoo (Multiple Colors)Israel
-
Venus ConceptTerminatedRemoval of Excess or Unwanted Body HairUnited States
-
AntriaCompletedSoft Tissue Mass RemovalUnited States
-
Assaf-Harofeh Medical CenterNot yet recruitingRetained Products of Conception | Endometrial Polyps | Lysis of Intrauterine Adhesions | Removal of Retained Intrauterine Device
-
Integra LifeSciences CorporationCompletedBenign, Malignant Tumors or Other Soft Tissue Removal | Nephrectomy or Partial Nephrectomy With Parenchyma RemovalGermany, Italy
Clinical Trials on Removal of fibrosynovial tissue
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Cambridge; Cambridge Stem Cell Institute, Cambridge; Anne McLarent... and other collaboratorsUnknownDiabetes Mellitus | Graft Rejection | TransplantationUnited Kingdom
-
University of HelsinkiRecruitingDeep Caries | Pulpitis Reversible | Pulp HyperemiaFinland
-
Juan Gonzalo OlivieriRecruitingDental Caries | Dental MaterialsSpain
-
Emory UniversityCompletedBreast Cancer | Breast Neoplasms | Breast Tumors | Neoplasms, Breast | Cancer of Breast | Cancer of the Breast | Human Mammary CarcinomaUnited States
-
Assuta Ashdod HospitalCompleted
-
University of PittsburghActive, not recruitingGender Dysphoria | TransgenderUnited States
-
Hologic, Inc.Completed
-
Faculty Sao Leopoldo Mandic CampinasCompleted
-
University of Nove de JulhoNot yet recruiting
-
University of TennesseeCompletedSecondary Infertility | Endocrine Disorders of Female Reproductive System | Infertility InvoluntaryUnited States